assessment: # note: the fact that this goes as "supporting" would be at the evidence line above this
  id: cg-fdp-ex:ps3-003
  type: CriterionAssessment
  description: NM_000314.4(PTEN):c.44G>A (p.Arg15Lys) meets PS3 criterion at supporting level of evidence
  criterion:
    id: SEPIO-CG:99025
    type: VariantPathogenicityInterpretationCriterion
    label: PS3
    description: well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product
    defaultStrength:
      id: SEPIO:000000330
      type: Code
      label: Pathogenic Strong
  variant:
    id: CAR:CA16613142
    type: CanonicalAllele
    label: NM_000314.4(PTEN):c.44G>A (p.Arg15Lys)
  statementOutcome:
    id: SEPIO:0000223
    type: Code
    label: Met
  evidenceLine:
    id: _:EvLn000
    type: EvidenceLine
    evidenceItem:
      id: _:Func000
      type: AlleleFunctionalImpactStatement
      resultDescription: p.Arg15Lys reduces PTEN gene product function
      canonicalAllele:
        id: CAR:CA16613142
      gene:
        id: HGNC:PTEN
        type: Gene
        label: Phosphatase and tensin homolog
      evidenceLine:
        id: _:EvLn001
        type: EvidenceLine
        evidenceItem:
        - id: _:FAEP000
          type: FunctionalAssayEvaluatesPathogenicity
          description: Abnormal PTEN localization predicts pathogenicity for PHTS with evidence level supporting
          assayInstance:
            id: _:FAI000
            type: FunctionalAssayInstance
            description: PTEN localization assay from PMID:25875300
            source: PMID:25875300 # (should this be contribution)
            experimentalMaterial:
              id: CLO:0002597
              label: COS-7 cell
            negativeControls: ["wt human PTEN"]
            replicates: 100
            assayType:
              id: _:FAT000
              type: FunctionalAssayType
              description: PTEN protein localization assay
              method:
                id: BAO:0002196
                label: Protein localization assay
          geneticCondition:
            id: _GC:000
            type: GeneticCondition
            disease: MONDO:0017623
            gene:
              id: HGNC:PTEN
            label: PTEN hamartoma tumor syndrome
            inheritancePattern:
              id: HP:0000006
              type: Code
              label: Autosomal dominant inheritance
            mechanism:
            - GO:0046856 (Phosphatidylinositol dephosphorylation)
            - GO:0005643 (Localization in nucleus)
            - GO:0030336 (Negative regulation of cell migration)
            - GO:0042127 (Regulation of cell proliferation)
          qualifiedContribution:
            id: _:VCEPEval000
            type: Contribution
            contributionRole:
              id: SEPIO:000154
              type: ContributionRole
              label: assessor
            agent:
              id: clingen-vcep:PTEN
              type: Agent
              label: ClinGen PTEN Expert Panel
            onBehalfOf: https://clinicalgenome.org
        - id: _:AFIMS000
          type: AlleleFunctionalImpactMeasurementStatement
          description: p.Arg15Lys alters PTEN protein localization in COS7 cells
          measurement: abnormal
          # units: ???
          canonicalAllele:
            id: CAR:CA16613142
          assayInstance:
            id: _:FAI000
          contribution:
          - id: _:QC000
            type: Contribution
            role: Publication
            agent: PMID:25875300
          - id: _:QC001
            type: Contribution
            role: Curator
            agent: clingen-people:JaneBiocurator
            onBehalfOf: clingen-vcep:RASopathy